Arkolith/Insider Trading/INO/Form 4

Weiner David B.

DirectorINOVIO PHARMACEUTICALS, INC. (INO) · full profile →Form 4 · filed Feb 28, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
7
3 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 27, 2023Sell(S)12K$1.28$15K904K
Feb 26, 2023Option exercise(M)12K——904K
Feb 26, 2023Option exercise(M)12K——916K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 27, 2023Grant(A)35K—$035K
Feb 27, 2023Grant(A)60K—$060K
Feb 26, 2023Option exercise(M)12K—$023K
Feb 26, 2023Option exercise(M)12K—$012K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001055726-23-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML